
Sign up to save your podcasts
Or
For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/SZN865. CME credit will be available until January 20, 2026.
Individualized Treatment for Generalized Myasthenia Gravis: Targeting the Cause and Prioritizing the Patient
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies).
Disclosure information is available at the beginning of the video presentation.
4.3
1010 ratings
For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/SZN865. CME credit will be available until January 20, 2026.
Individualized Treatment for Generalized Myasthenia Gravis: Targeting the Cause and Prioritizing the Patient
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies).
Disclosure information is available at the beginning of the video presentation.
5 Listeners
3 Listeners
3 Listeners
5 Listeners
27 Listeners
10 Listeners
3 Listeners
2 Listeners
4 Listeners
3 Listeners
288 Listeners
3 Listeners
5 Listeners
5 Listeners
2 Listeners
129 Listeners
0 Listeners
9 Listeners
2 Listeners
15,063 Listeners
50 Listeners
10 Listeners
44 Listeners
2 Listeners
493 Listeners
111,761 Listeners
56,180 Listeners
1,090 Listeners
7,910 Listeners
289 Listeners
556 Listeners
12,918 Listeners
28,304 Listeners
112 Listeners